Literature DB >> 33600452

Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis.

Kunkun Wang1,2, Zhenfan Wang1, Qiaozhu Zeng1, Lijuan Zhu3, Jingyuan Gao4, Ziqiao Wang1, Shanshan Zhang5, Fei Yang6, Danhua Shen6, Yi Wang7, Yanying Liu1.   

Abstract

Retroperitoneal fibrosis (RPF) is an uncommon condition characterized by inflammation and fibrosis in the retroperitoneal space. More than two-thirds of RPF are idiopathic, with the remaining stemed from a variety of secondary causes. It was suggested that IgG4-related RPF is a secondary form of RPF. We undertook this study to compare detailed demographic, clinical and laboratory characteristics of IgG4-related RPF and IRPF in a large Chinese cohort. We retrospectively reviewed the medical records of 132 RPF patients diagnosed at Peking University People's Hospital between March 2010 and March 2018. Among the 132 patients, the mean age at disease onset was 54.8 years. IgG4-related RPF group showed greater male predominance compared to IRPF group. IgG4-related RPF patients showed a longer interval between symptom onset and diagnosis, and allergic diseases were more common in this group. Sixty-four patients (48.4%) had lower back pain, which was more common in IRPF group than that in IgG4-related RPF patients. In terms of organ involvement, although 42 of 47 patients (89.3%) with IgG4-related RPF had other organ involvement, there were no patients in the IRPF group with other organ involvement. In addition, the serum IgG4 level, elevated eosinophils counts and IgE level were significantly higher in IgG4-related RPF patients. We described the demographic, clinical and laboratory differences between IgG4-related RPF and IRPF patients, indicating their potential differences in pathogenesis, which was of great importance to diagnose and manage the two phenotypes.

Entities:  

Year:  2021        PMID: 33600452      PMCID: PMC7891782          DOI: 10.1371/journal.pone.0245601

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  36 in total

Review 1.  Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease.

Authors:  James R Stone
Journal:  Curr Opin Rheumatol       Date:  2011-01       Impact factor: 5.006

Review 2.  Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease.

Authors:  Giovanni Maria Rossi; Rossana Rocco; Eugenia Accorsi Buttini; Chiara Marvisi; Augusto Vaglio
Journal:  Intern Emerg Med       Date:  2017-01-09       Impact factor: 3.397

3.  IgG4-related periaortitis vs idiopathic periaortitis: is there a role for atherosclerotic plaque in the pathogenesis of IgG4-related periaortitis?

Authors:  Thomas Castelein; Walter Coudyzer; Daniel Blockmans
Journal:  Rheumatology (Oxford)       Date:  2015-01-12       Impact factor: 7.580

4.  Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.

Authors:  Hyun Woo Lee; Sung-Hoon Moon; Myung-Hwan Kim; Dong Hui Cho; Jae Hyuck Jun; Kwangwoo Nam; Tae Jun Song; Do Hyun Park; Sang Soo Lee; Dong-Wan Seo; Sung Koo Lee
Journal:  J Gastroenterol       Date:  2018-01-23       Impact factor: 7.527

5.  Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease.

Authors:  Shounak Majumder; Sonmoon Mohapatra; Ryan J Lennon; Guilherme Piovezani Ramos; Neil Postier; Ferga C Gleeson; Michael J Levy; Randall K Pearson; Bret T Petersen; Santhi Swaroop Vege; Suresh T Chari; Mark D Topazian; Thomas E Witzig
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-08       Impact factor: 11.382

6.  Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation.

Authors:  E F H van Bommel; I Jansen; T R Hendriksz; A L H J Aarnoudse
Journal:  Medicine (Baltimore)       Date:  2009-07       Impact factor: 1.889

7.  Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone.

Authors:  Eric F H van Bommel; Claire Siemes; Liesbeth E Hak; Sacha J van der Veer; Tadek R Hendriksz
Journal:  Am J Kidney Dis       Date:  2007-05       Impact factor: 8.860

8.  Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort.

Authors:  Yanying Liu; Qiaozhu Zeng; Lijuan Zhu; Jingyuan Gao; Ziqiao Wang; Zhenfan Wang; Fei Yang; Kunkun Wang; Da Chen; Changsheng Xia; Shanshan Zhang; Yi Wang; Danhua Shen; Guangyan Yu; Zhan-Guo Li
Journal:  Rheumatology (Oxford)       Date:  2020-08-01       Impact factor: 7.580

9.  The clinical significance of retroperitoneal fibrosis.

Authors:  L Koep; G D Zuidema
Journal:  Surgery       Date:  1977-03       Impact factor: 3.982

10.  Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases.

Authors:  Satomi Kasashima; Atsuhiro Kawashima; Fuminori Kasashima; Masamitsu Endo; Yasushi Matsumoto; Kengo Kawakami
Journal:  Heart Vessels       Date:  2018-06-21       Impact factor: 2.037

View more
  1 in total

Review 1.  Renal Involvement in Retroperitoneal Fibrosis: Prevalence, Impact and Management Challenges.

Authors:  Ichiro Mizushima; Mitsuhiro Kawano
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-07-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.